Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
The report shows strong growth in Asian markets, with India at 8.8% CAGR, followed by China (8.7%) and South Korea (8.6%).
Future Market Insights3d
Global Small Molecule API Market Set to Reach USD 186,941.2 Million by 2034, Growing at a CAGR of 4.5%
Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...
The Rise Of India’s Pharmaceutical Industry To A Forecasted $450 Billion
India is showing real commitment to realize its vision of becoming a “pharmacy of the world” by implementing policies and ...
ABP Live on MSN4d
Chinese Pharma Major Shanghai Pharma Seeking API Imports From India
Chinese pharmaceutical giant Shanghai Pharmaceuticals Holding Co. Ltd is keen on importing active pharmaceutical ingredients ...
API prices expected to stabilise by Q4FY25, says Akums Drugs’ Maheshwari
API prices have been under pressure over the past few quarters due to weak demand and competition from China in export ...
How Asian pharma suppliers cash in on Ozempic copies
Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...
Taiwan News6d
Saudi Arabia Active Pharmaceutical Ingredients (API) Market Growth, Size, Revenue Projections, and Competitive Landscape, 2024-2032
Report Ocean has published a new report on the Saudi Arabia Active Pharmaceutical Ingredients (API) Market, delivering an extensive analysis of key factors such as market restraints, drivers, and ...
Natco Pharma Q2 net surges 83% to ₹677 crore on robust growth in formulation exports
Generic drugmaker Natco Pharma consolidated net profit surged 83% to ₹676.5 crore for the quarter ended September, from ₹369 ...